MA H2384

Healthcare providers participating in state immunization programs must be allowed to select any brand or type of vaccine, including combination vaccines and dosage forms, as long as it is FDA-licensed or authorized and CDC-recommended

The Department of Public Health cannot limit providers' vaccine choices by restricting the supply of immunizations it purchases, except during shortages, public health emergencies, disasters, or security threats

Restructures the Vaccine Program Advisory Council to include representatives from the Commissioner of Public Health, MassHealth, the three largest health insurers, medical societies, and physicians with childhood vaccine expertise

Annual surcharge increases for the Vaccine Purchase Trust Fund are capped at the state health care cost growth benchmark, with increases above that threshold requiring a detailed report to legislative committees

Full implementation of the provider immunization brand choice requirement is mandated by July 1, 2025